Multiplex amplification of polynucleotides

US9822405B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9822405-B2
Application numberUS-201514752396-A
CountryUS
Kind codeB2
Filing dateJun 26, 2015
Priority dateDec 4, 2002
Publication dateNov 21, 2017
Grant dateNov 21, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides methods, reagents and kits for carrying out a variety of assays suitable for analyzing polynucleotides or samples that include an amplification step performed in a multiplex fashion. Also provided are methods for analyzing and improving the efficiency of amplification and for carrying out gene expression analysis.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of generating a plurality of target sequences of interest, comprising the step of: amplifying one or more target polynucleotides in the presence of a plurality of amplification primers suitable for amplifying a plurality of target sequences of interest and in the presence of a plurality of labeled oligonucleotide probes, wherein each of the plurality of labeled oligonucleotide probes is complementary to a region of an amplified target sequence of interest and has the same label suitable for monitoring amplification as a function of time. 2. The method of claim 1 in which the product of the amplification is further subjected to at least one assay selected from the group consisting of single polynucleotide polymorphism analysis, genotyping analysis, gene expression analysis, fingerprinting analysis, analysis of gene mutations for genetic diagnoses, analysis of rare expressed genes in cells, nucleic acid sequencing, nucleic acid mini-sequencing and gene expression analysis. 3. The method of claim 1 in which the product of the amplification is further subjected to at least one assay selected from the group consisting of chromatography, electrophoresis, and staining with a dye or hybridization probe. 4. The method of claim 1 in which the product of the amplification is divided into a plurality of aliquots. 5. The method of claim 2 in which the product of the amplification is divided into a plurality of aliquots and wherein said at least one assay is performed on at least one of said aliquots. 6. The method of claim 5 wherein the number of aliquots is equal to the number of primer pairs used in said amplifying. 7. The method of claim 1 in which the amplification is carried out in the presence of uracil N-glycosylase. 8. The method of claim 1 wherein the one or more target polynucleotides is a plurality of target polynucleotides. 9. The method of claim 1 wherein the one or more target polynucleotides comprise a cDNA library. 10. The method of claim 1 wherein the amplifying is achieved with a thermostable DNA polymerase. 11. The method of claim 1 wherein the plurality of labeled oligonucleotides probes is selected from the group consisting of 5 ′-exonuclease probes, stem-loop beacon probes, and stemless beacon probes. 12. The method of claim 1 wherein the label is a fluorophore. 13. The method of claim 1 wherein the amplifying is by a polymerase chain reaction carried out for a number of cycles such that the amplification remains in the linear range. 14. The method of claim 1 wherein the amplifying comprises 10 to 20 polymerase chain reaction cycles. 15. The method of claim 1 wherein the amplifying comprises 2 to 14 polymerase chain reaction cycles. 16. The method of claim 1 wherein at least 50% of the amplification primers are present at concentrations in the range from 30 nM to 100 nM for each primer. 17. The method of claim 1 wherein at least 50% of the amplification primers are present at approximately equimolar concentration from 30 nM to 100 nM for each primer.

Assignees

Inventors

Classifications

  • C12Q1/6827Primary

    for detection of mutation or polymorphism · CPC title

  • Quantitative amplification · CPC title

  • Taqman · CPC title

  • Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis · CPC title

  • Real time assay · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9822405B2 cover?
The present invention provides methods, reagents and kits for carrying out a variety of assays suitable for analyzing polynucleotides or samples that include an amplification step performed in a multiplex fashion. Also provided are methods for analyzing and improving the efficiency of amplification and for carrying out gene expression analysis.
Who is the assignee on this patent?
Applied Biosystems Llc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6827. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).